VulnerabilityModified
CVE-2020-12037
An attacker could observe sensitive data sent from the device.
HIGH 7.5EPSS 0.48%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.48%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS (Patient Data Management System) or an EMR (Electronic Medical Record) system. An attacker could observe sensitive data sent from the device.
- CVSS 3.1
- 7.5 HIGHCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- EPSS
- 0.48% probability · 40th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-259, CWE-319
- Affected
- baxter/prismaflex firmware · baxter/prismax firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01Not Applicable
- https://us-cert.cisa.gov/ics/advisories/icsma-20-170-02Third Party Advisory
- https://www.us-cert.gov/ics/advisories/icsma-20-170-01Not Applicable
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.